NCT07718516

Brief Summary

This pilot study evaluates the feasibility, usability, and clinical utility of the Woddle Smart Changing Pad and companion mobile application for infant monitoring following hospital or NICU discharge. The study also compares infant weight measurements obtained using the Woddle scale with those from standard clinical reference scales to assess accuracy and reliability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 16, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 6, 2026

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 14, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 22, 2026

Completed
Last Updated

July 22, 2026

Status Verified

July 1, 2026

Enrollment Period

7 months

First QC Date

July 14, 2026

Last Update Submit

July 17, 2026

Conditions

Keywords

digital healthremote patient monitoringsmart scaleneonatal weight monitoringpost discharge careconnected device

Outcome Measures

Primary Outcomes (4)

  • Caregiver adherence

    Proportion of study days (of 84) with valid device use.

    12 weeks.

  • Agreement between device and clinic reference weight

    Mean bias, Bland-Altman limits of agreement, and intraclass correlation coefficient (ICC) between paired device and clinic scale weights.

    Baseline, Week 6, and Week 12.

  • Data sync success rate

    Proportion of expected device-to-dashboard data syncs successfully received

    12 weeks.

  • Caregiver System Usability Scale (SUS) score

    10-item, 5-point Likert usability scale (range 0-100).

    Week 6 and Week 12.

Secondary Outcomes (6)

  • Infant weight gain trajectory

    12 weeks

  • Nadir weight

    12 weeks

  • Healthcare utilization

    12 weeks.

  • Caregiver confidence and stress

    Baseline vs. Week 12.

  • Provider usability and satisfaction

    Week 12.

  • +1 more secondary outcomes

Study Arms (1)

Woddle Device Group

EXPERIMENTAL

All enrolled caregiver-infant dyads received the Woddle Smart Changing Pad and companion mobile application for home use over a 12-week period, with data reviewed by participating providers via a secure dashboard.

Device: Woddle Smart Changing Pad

Interventions

A sensor-enabled infant changing pad with an integrated precision weight scale, capturing diaper events, feeding sessions, and sleep duration through caregiver input and sensors. Data sync to a companion mobile application and a secure, HIPAA-compliant provider dashboard.

Also known as: Woddle Baby smart changing pad and app
Woddle Device Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Born at gestational age 23-0 to 42-0 weeks
  • Discharged from NICU or couplet/newborn care within 45 days prior to planned enrollment
  • Clinical indication for post-discharge growth or feeding follow-up, or documentation of a qualifying ICD-10/P-code (perinatal/growth-related, feeding/nutrition, growth/weight monitoring, or follow-up/well-newborn codes)
  • Twins/triplets permitted (one device shared per family)
  • Age ≥ 18 years
  • Primary language English, Spanish, or Chinese
  • Access to a smartphone compatible with the study app and home Wi-Fi/data plan
  • Willing and able to complete study tasks over 12 weeks of home monitoring

You may not qualify if:

  • Rehospitalized within 7 days prior to planned enrollment
  • Conditions making participation inappropriate or unsafe in the opinion of the treating clinician or investigator
  • Enrolled in another interventional study that conflicts with device monitoring or study endpoints
  • Declines or is unable to provide informed consent
  • Unable or unwilling to operate the device/app after training and reasonable technical support
  • Unwilling to allow collection of study data or provider/staff access to relevant clinical event data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

HITLAB, 175 Varick St 4th floor New York

New York, New York, 10014, United States

Location

Pediatrics 2000 III Pllc, 505 West 168th St Fl.1 NY

New York, New York, 10032, United States

Location

Vermenton Pediatrics, 1055 E Tremont Ave, Bronx

The Bronx, New York, 10460, United States

Location

MeSH Terms

Conditions

Infant Nutrition DisordersWeight LossPremature Birth

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chair of the Healthcare Innovation Technology Laboratory

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 22, 2026

Study Start

December 16, 2025

Primary Completion

July 6, 2026

Study Completion

July 13, 2026

Last Updated

July 22, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared beyond the study team due to the small pilot sample size (N≈10 caregiver-infant dyads), which creates a meaningful risk of participant re-identification even after de-identification, given the combination of detailed clinical, demographic, and continuous home-monitoring data collected. Additionally, the informed consent obtained from participating caregivers did not include provisions for depositing or sharing individual-level data with external researchers. De-identified, aggregate findings will be made available through peer-reviewed publication and supplemental materials.

Locations